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A polar metabolite of leukotriene Cd was formed by sequential conversions with soybean lipoxygenase I 
and liver peroxidase. The structure of this product was found to be S(s),l5(S)-dihydroxy-6(R)& 
glutathionyl-7,9,13-trans-1 I-cis-eicosatetraenoic acid (15-hydroxy-Ar3-trans-leukotriene C3). The HPLC 
behaviour, the molar extinction coefficient and the biological activity of the metabolite are reported. 
Preliminary evidence suggests that this product is formed by mammalian tissues. 
I5-Hydroxy leukotriene SRS-A 
Guinea pig ileum bioassay 
1. INTRODUCTION 
In experiments with homogenates and isolated 
organs from different animal species [ 1,2] and also 
in in vivo experiments [3,4] a rapid and extensive 
metabolism of leukotrienes has been observed. In- 
creasing amounts of polar metabolites are formed 
with time. Presumably, different kinds of oxy- 
genations are involved in the formation of such 
products. Lipoxygenases are enzymes that 
stereospecifically introduce a molecule of oxygen 
into polyunsaturated fatty acids. They play an im- 
portant role in the metabolism of arachidonic acid 
and initiate the pathways leading to hydroxy acids, 
prostanoids* and leukotrienes. 
Soybean lipoxygenase-1 inserts oxygen at the 
C-15 position of arachidonic acid. It requires a 
* The initial step catalyzed by prostaglandin endoperox- 
ide synthase (fatty acid cyclooxygenase) involves 
stereospecific addition of molecular oxygen at C-l 1 of 
precursor acids and can be regarded as a lipoxygenase- 
type of reaction 
Abbreviations: HPLC, high performance liquid 
chromatography; WHETE, 15hydroxy 
eicosatetraenoic acid; UV, ultraviolet 
Lipoxygenase product 
UV spectroscopy 
HPLC 
cis,cis-1,6pentadiene structure in the substrate 
with a methylene carbon at w-8. This structural 
specificity was used to determine the positions of 
the three conjugated double bonds in leukotriene 
Cd and the position of the sulfur containing substi- 
tuent [5,6]. The product formed by the action of 
soybean lipoxygenase on leukotriene C4 was 
however, not previously characterized. Since 
several animal tissues and cells contain enzyme(s) 
which converts arachidonic acid to 
15hydroperoxy-5,8,11,13-eicosatetraenoic acid 
[7-l l] it seemed of interest to isolate the products 
formed by the action of soybean lipoxygenase on 
leukotriene C4 and its congeners leukotriene D4 
[ 121 and leukotriene E4 [ 131. The metabolites were 
enzymatically reduced and characterized chemical- 
ly. The biological activity on isolated guinea pig il- 
eum was also determined. 
2. MATERIALS AND METHODS 
2.1. Materials 
Soybean lipoxygenase type 1 (EC 1.13.11.12) 
was purchased from Sigma Chemical Co. FPL 
55712 was provided by P. Sheard of Fisons Phar- 
maceuticals (Loughborough). [5,6,8,9,11,12,14,15- 
‘Hs]Leukotriene C4 was prepared using 5,8,11,14- 
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eicosatetraenoic acid as starting material according 
to [l]. Leukotrienes Dq and Eq were obtained by 
enzymatic degradation from leukotriene Cd 
[ 12,131. Synthetic leukotrienes Cd, D4 and E4 were 
kindly provided by J. Rokach, Merck-Frosst of 
Canada Inc. All leukotrienes were purified by 
reverse phase HPLC before use. 
2.2. Preparation of high-speed supernatant from 
mouse liver 
Livers from two mice were minced and 
homogenized in Tyrode’s buffer (2 ml/g wet wt) at 
0°C for 90 s using a Potter-Elvehjem 
homogenizer. The mixture was centrifuged at 600 
x g and 0°C for 15 min. The supernatant was 
decanted and recentrifuged at 60000 x g and 0°C 
for 20 min. This high speed supernatant was 
frozen in 2 ml fractions or used immediately. 
2.3. Incubations 
Leukotriene C4 (20 nmol) plus 2 &i 
t3H]leukotriene C4 (10 Ci/mmol) were evaporated 
to dryness under a stream of argon and dissolved 
in 5 ml of Tyrode’s buffer. Soybean lipoxygenase 
(50~1; 1 mg/ml) was added and the mixture was 
kept at room temperature. The reaction was 
followed by UV spectroscopy every 5 min with 
scanning between 220-350 nm in a Cary 219 spec- 
trophotometer. After 35 min no further increase in 
absorption at 307 nm was observed. High speed 
supernatant from mouse liver (5 ml) was then add- 
ed and the mixture was incubated at 37°C for 
15 min. 
After addition of 5 vol. ethanol the mixture was 
left on ice for 30 min and then centrifuged at 1200 
rev./min and 4°C for 5 min. The supernatant was 
decanted and the pellet was resuspended in 5 ml 
ethanol and recentrifuged. The two supernatants 
were pooled, evaporated to dryness and dissolved 
in 2 ml HPLC-phase. The preparations were then 
purified by HPLC with a column of C~S Polygosil 
(500 x 10 mm) using methanol/water/acetic acid 
(65:35:0.1, by._vol.; adjusted to pH 5.4 with 
N&OH) as mobile phase. The products were 
detected by their UV-absorption at 307 nm. 
Preparations of hydroxylated metabolites of 
leukotrienes D4 and E4 were analogous except that 
10 nmol (100 Ci/mol) of each compound were 
used. 
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2.4. Bioassay 
Bioassay was performed on isolated guinea pig 
ileum in Tyrode’s buffer containing atropine 
sulfate (1 PM) and mepyramine maleate (1 PM). 
3. RESULTS AND DISCUSSION 
Products having conjugated tetraenes as judged 
by UV spectroscopy were formed by the action of 
soybean lipoxygenase on leukotrienes Cd, D4 and 
Ed. These products, which probably contained a 
hydroperoxy group, were reduced to the cor- 
responding hydroxy metabolites by incubations 
with high speed supernatant from mouse liver 
homogenates. The reaction velocity in the lipoxy- 
genase reaction was about 1.7- and 3.5-times 
higher for leukotrienes D4 and Ed, respectively, 
compared with leukotriene Cd. 
Fig.1 shows an HPLC-chromatogram for the 
product obtained from leukotriene Cd. The reten- 
tion time was 0.33 relative to leukotriene C4. The 
metabolite from leukotriene D4 and that from 
leukotriene E4 had the same retention time (0.46 
relative to leukotriene Cd). 
The product from leukotriene Cd was treated 
with y-glutamyl transpeptidase [ 121. Analyses by 
HPLC showed traces of the product formed from 
leukotriene C4 and a less polar metabolite. The less 
polar product was found to be identical to the pro- 
Fig.1. HPLC chromatogram of a metabolite formed 
from leukotriene Cb by the action of soybean 
lipoxygenase and liver peroxidase (elution time = 
15 min). The arrow indicates the elution time of 
corresponding products formed from leukotrienes D4 
and E4 in separate experiments (21 min). For further 
details on formation of leukotriene metabolites and 
HPLC, see section 2. 
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duct obtained by treating leukotriene D4 with soy- 
bean lipoxygenase and high speed supernatant 
from mouse liver homogenates. 
Fig.2 shows the UV-spectrum of the product 
from leukotriene C4. The spectrum has an absor- 
bance maximum at 307 nm and shoulders at 
294 nm and 322 nm. Since the specific activity of 
the tritium labeled leukotriene C4 used as substrate 
was known, the molar extinction coefficient (6) for 
the product could be calculated from UV absor- 
bance and radioactivity measurements (73000 at 
307 nm, 59000 at 322 nm and 52000 at 294 nm; 
solvent: methanol/water/acetic acid, 65 : 35 : 0.1 
(by vol.) adjusted to pH 5.4 with NH40H). 
UV-spectra of the products from leukotrienes D4 
and E4 were similar to that of the leukotriene C4 
metabolite (not shown). The UV-spectra and the 
extinction coefficients are compatible with a con- 
jugated tetraene structure having an allylic 
thioether substituent. 
Desulfurization of the leukotriene C4 product 
with Raney nickel and subsequent analyses by 
gas-liquid chromatography/mass spectrometry of 
the trimethylsilylether, methylester derivative 
showed a component at C-24.2 (OV-1) with ions at 
m/z 487(M-15), 471(M-31), 431(M-71), 365, 
341(M-(90 +71)), 311(M-(101 + 90)), 203(Me$SiO- 
- CH-(CHz)sCOOCH3) and 173(Me$iO- 
- CH-(CH&CH,). The spectrum was identical to 
that of 5,15-dihydroxyeicosaenoic acid (methyl 
ester, bis trimethylsilylether derivative [ 141). 
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Fig.2. Ultraviolet spectrum of the metabolite of Fig.3. Structure and formation of 15(S)-hydroxy- 
leukotriene Cq isolated by HPLC in fig. 1. The spectrum A13-trans-leukotriene C3 from leukotriene C4 by 
was recorded in methanol : water : acetic acid 65 : 35 : 0.1 sequential conversions with soybean lipoxygenase and 
(by vol.) adjusted to pH 5.4 by N&OH. liver peroxidase. 
Based on the UV spectrum, the formation of 
5,15-dihydroxyeicosaenoic acid by catalytic 
desulfurization and the conversion of the reduced 
lipoxygenase product of leukotriene C4 during the 
incubations with y-glutamyl transpeptidase the 
structure of the leukotriene C4 metabolite is 
5,15-dihydroxy-16-S-glutathionyl-7,9,11,13- eicosa- 
tetraenoic acid. The configuration of the 15-hydro- 
xyl group is probably (5) and geometry of the Al3 
double bond is probably tram by analogy with the 
soybean lipoxygenase product formed from 
arachidonic acid [ 151. Thus, the complete structure 
of the metabolite is 5(s), 15(S)-dihydroxy- 
6(R)-S-7,9,13-trans-l l-cis-eicosatetraenoic acid 
(15(S)-hydroxy-A “-trans-leukotriene C3). By the 
same nomenclature the products obtained from 
leukotrienes D4 and E4 are 15(S)-hydroxy-A13- 
trans-leukotrienes D3 and E3, respectively. The 
formation and structure of the leukotriene C4 
metabolite are shown in fig.3. 
&OOH 
~HCONHCH2COOH , 
liHCO(CH2)2 CHCOOH 
AH2 
NHCO(CH212 FHCOOH 
COOH 
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Fig.4. Contractile effects of leukotriene Cd and 
15-hydroxy-A’3-trans-leukotriene C3 on isolated guinea 
pig ileum. The upper part shows recordings of 
contractions of guinea pig ileum after addition of 
leukotriene C4 (309 pmol) and 15hydroxy- 
A’3-ieukotriene C3 (336 pmol) to the organ bath. The 
lower part shows dose response curves for leukotriene CA 
(.-. at 4 min and C--C at 2 min) and 15hydroxy- 
A13-leukotriene C3 (x-x at 4 min and M at 2 min 
after injection to the organ bath). 
Fig.4 shows dose-response curves for 
15-hydroxy-A13-leukotriene C3 and leukotriene C4 
on isolated guinea pig ileum. 15Hydroxy- 
A13-leukotriene C3 gave a contraction that was 
reversed by the addition of FPL 55712. On a molar 
basis 1 5-hydroxy-A’3-leukotriene C3 was 
7-l l-times less potent than leukotriene Cq. A lag 
phase of about 3 min occurred between the injec- 
tion of 15-hydroxy-Ar3-leukotriene C3 and the 
onset of the contraction. After 2 min when the 
contraction due to leukotriene G was almost max- 
imal, no contraction was observed with 
15-hydroxy-A13-leukotriene C3. The lag phase may 
suggest that 15-hydroxy-Ar3-leukotriene C3 was 
metabolized further prior to eliciting the 
contraction. 
To sum&arize, leukotriene C4 is metabolized by 
introduction of oxygen at C-15. This transforma- 
tion diminishes the contractile activity on ileum 
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with about 90%. The contribution of mammalian 
15-lipoxygenases to leukotriene Cd metabolism is 
presently being investigated. 
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